Leidos Holdings, Inc. (NYSE:LDOS) Q4 2025 Earnings Call Transcript
Leidos Holdings, Inc. (NYSE:LDOS) Q4 2025 Earnings Call Transcript February 17, 2026Leidos Holdings, Inc. beats earnings expectations.
Insider Monkey Blog
Medtronic plc (NYSE:MDT) Q3 2026 Earnings Call Transcript
Ingrid Goldberg: Good morning, and welcome to our Fiscal '26 Third Quarter Earnings Webcast.
Energy Transfer LP (NYSE:ET) Q4 2025 Earnings Call Transcript
Energy Transfer LP (NYSE:ET) Q4 2025 Earnings Call Transcript February 17, 2026Energy Transfer LP misses on earnings expectations.
Otter Tail Corporation (NASDAQ:OTTR) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Otter Tail Corporation Fourth Quarter 2025 Earnings Conference Call. Today’s call is being recorded.
Armada Hoffler Properties, Inc. (NYSE:AHH) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Armada Hoffler Properties, Inc. Fourth Quarter 2025 Earnings Call.
Sonoco Products Company (NYSE:SON) Q4 2025 Earnings Call Transcript
Roger Schrum: Let me make sure we're there. Again, good morning, everyone, and thanks for joining us at today's Sunoco's 2026 Investor Day.
Grupo Aeroméxico, S.A.B. de C.V. (NYSE:AERO) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Aeromexico Fourth Quarter 2025 Financial Results. [Operator Instructions] As a reminder, today's conference is being recorded.
ReNew Energy Global Plc (NASDAQ:RNW) Q3 2026 Earnings Call Transcript
ReNew Energy Global Plc (NASDAQ:RNW) Q3 2026 Earnings Call Transcript February 16, 2026ReNew Energy Global Plc beats earnings expectations.
NatWest Group plc (NYSE:NWG) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to NatWest Group's Full Year 2025 Results Management Presentation.
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) Q3 2026 Earnings Call Transcript
Nathan Fast: Hello and welcome to today's webcast on HIVE Digital Technologies Ltd. Financial Results for the Quarter Ended December 31, 2025.
cbdMD, Inc. (AMEX:YCBD) Q1 2026 Earnings Call Transcript
Operator: Good afternoon. Welcome, ladies and gentlemen, to cbdMD Inc.'s December 31, 2025, First Fiscal Quarter of 2026 Earnings Call and Update.
Public Storage (NYSE:PSA) Q4 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Public Storage Fourth Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Agnico Eagle Mines Limited (NYSE:AEM) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. My name is Vanessa, and I will be your conference operator today.
Precision Optics Corporation, Inc. (NASDAQ:POCI) Q2 2026 Earnings Call Transcript
Operator: Good day, and welcome to the Precision Optics Reports Second Quarter Fiscal Year 2026 Financial Results Conference Call.
Core Natural Resources, Inc. (NYSE:CNR) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Core Natural Resources, Inc. Fourth Quarter 2025 Earnings Call.
Palatin Technologies, Inc. (AMEX:PTN) Q2 2026 Earnings Call Transcript
Operator: Greetings. Welcome to Palatin's Second Quarter Fiscal Year 2026 Operating Results Conference Call.
Vale S.A. (NYSE:VALE) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to Vale's Fourth Quarter 2025 Earnings Call.
Will Coherent Corp. (COHR) Benefit from Transition?
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
Do You Think Hims & Hers Health (HIMS) is Positioned for Long-Term Growth?
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
Should You Hold Varonis Systems (VRNS)?
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
Here’s Why Investors Favour Woodward (WWD)
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
12 Best Single Digit Stocks to Buy According to Analysts
On January 27, Matt Stucky of Northwestern Mutual appeared on CNBC's 'Closing Bell Overtime' to discuss the shifting landscape of the 2026 stock market with a focus on the broadening...
10 Best Stocks to Buy and Hold for the Next 6 Months
Investors are becoming more selective toward tech stocks amid valuation concerns, with the overall market at all-time highs.
12 Oversold Financial Stocks to Invest in According to Hedge Funds
On January 21, Morgan Stanley shared its 2026 market outlook, highlighting key catalysts and risk factors.
11 Best Money-Making Stocks to Buy Right Now
In an environment marked by shifting rate expectations and growth volatility, investors remain focused on identifying companies capable of delivering sustainable earnings expansion...
Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion
TheFly reported on February 6 that Morgan Stanley increased its price target on PAHC to $49 from $45 and maintained an Equal Weight rating.
Collegium Pharmaceutical, Inc. (COLL) Gains Momentum on Jornay PM, Truist Highlights Robust Pain Portfolio
TheFly reported on February 10 that Truist Securities analyst Les Sulewski raised its price target on COLL to $58 from $55 and gave it a Buy rating. The analyst emphasized ...
Amneal Pharmaceuticals, Inc. (AMRX) Added to S&P SmallCap 600 Index, Boosting Investor Visibility
Separately, on January 29, Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced that it would be added to the S&P SmallCap 600 Index. It is a popular benchmark for U.S.
TD Cowen Updates Financial Model Citing Upcoming Q4 Results for Lantheus Holdings, Inc. (LNTH)
TheFly reported on January 29 that TD Cowen lowered its price target on LNTH to $75 from $80 and gave it a Buy rating.
Bank of America Cites Zoetis Inc.’s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook
TheFly reported on February 13 that Bank of America raised its price target for ZTS to $140 from $135 and maintained a Neutral rating on the shares. The upgraded target was...
UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade
TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11.
Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions
TheFly reported on February 4 that Barclays lowered its price target on LEGN to $80 from $90 and maintained an Overweight rating on the shares. Although the long-term forecast...
BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)’s Growth, Projecting Peak Sales Above $11B
TheFly reported on February 5 that Bank of America (BofA) initiated coverage of WVE with a Buy rating and a price target of $38.
Stifel Views Downtime as Attractive Entry Opportunity for Hinge Health, Inc. (HNGE) Shares
TheFly reported on February 5 that Stifel lowered its price target on HNGE to $59 from $66 and maintained a Buy rating on the shares.
Fiserv (FISV) Jumps Over 6% as Activist Investor Gobbles Stake
Fiserv grew its share prices by 6.89 percent on Tuesday to finish at $63.45 apiece as investors mirrored an activist group’s acquisition of a significant stake in a bid to boost...
Under Armour (UA) Surges 8.18% on Milestone Shoe Launch
Under Armour rallied for a third straight day on Tuesday, jumping 8.18 percent to finish at $7.54 apiece as investors resumed buying positions following the launch of its final...
Waystar (WAY) Climbs 8.5% on Swing to Profits, Double-Digit Outlook
Waystar saw its share prices jump by 8.48 percent on Tuesday to close at $24.31 apiece as investors cheered its swing to profitability and a double-digit growth outlook for this...
Kyndryl (KD) Soars 11% on Financial Statement Compliance
Kyndryl Holdings rallied for a second day on Tuesday, jumping 11.03 percent to finish at $13.59 apiece as investors resumed buying positions following the successful submission...
Norwegian Cruise (NCLH) Soars 12% as Activist Firm Buys Stake
Norwegian Cruise saw its share prices jump by 12.15 percent on Tuesday to finish at $24.10 apiece as investors mimicked an activist group’s acquisition of a 10 percent stake...
National Energy (NESR) Propels to All-Time High on Earnings Beat
In an updated report, National Energy Services Reunited Corp.
eToro (ELOR) Climbs 20% on Earnings Buyout, Buyback Hike
eToro grew its share prices by 20.43 percent on Tuesday to finish at $33.07 apiece as investors gobbled up shares following a strong earnings performance and news of a higher ...
ZIM Integrated (ZIM) Soars to Record High on $4.2-Billion Takeover
ZIM Integrated rallied to an over three-year high on Tuesday, as investors gobbled up shares following news that it was set to be acquired by German shipping giant Hapag-Lloyd...
Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks
TheFly reported on February 4 that Mizuho lowered its price target on WAY to $42 from $50 while maintaining an Outperform rating.
Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal
TheFly reported on February 10 that Deutsche Bank lowered its price target on HIMS to $31 from $42 and maintained a Hold rating on the shares.
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81
TheFly reported on February 6 that Baird lowered its price target for HAE to $81 from $99 while maintaining an Outperform rating.
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside
TheFly reported on February 9 that Canaccord Genuity upgraded DOCS from Hold to Buy and lowered the price target to $34 from $48.
Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth
TheFly reported on February 3 that Truist raised its price target on CYTK to $92 from $84 and maintained a Buy rating. The company revised its model ahead of its Q4 results...
Travere Therapeutics, Inc. (TVTX) Positioned for Long-Term Growth in Rare Disease Market
TheFly reported on February 6 that Piper Sandler raised its price target on TVTX to $38 from $35 and maintained a Neutral rating on the shares.
Hedge Fund Resource Center
